Hematologic Malignancies
News
GENUINE improvements: Ublituximab plus ibrutinib for CLL
News
CLL patients: Diagnostic difficulties, treatment confusion with COVID-19
News
COVID-19 vaccine failure in patients with blood cancers
News
Steroids can be stopped in some older multiple myeloma patients
News
First CAR T-cell therapy for multiple myeloma: Abecma
“The results of this trial represent a true turning point in the treatment of this disease.”
News
Concern over response to COVID-19 in patients with blood cancers
Case Reports
Sequential Targeted Treatment for a Geriatric Patient with Acute Myeloid Leukemia with Concurrent FLT3-TKD and IDH1 Mutations
Targeting and monitoring several acute myeloid leukemia mutations sequentially provides insights into optimal treatment plans.
News
Experts offer roadmap for treating CLL during the pandemic
Conference Coverage
Study found dual-targeted CAR T highly active against relapsed/refractory multiple myeloma
Conference Coverage
Synthetic lethality: Triple combination is a viable strategy for B-cell malignancies